Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Materials
Create a narrative
AptarGroup Community
NYSE:ATR Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Community Investing Ideas
AptarGroup
Popular
Undervalued
Overvalued
AptarGroup
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Advanced Drug Delivery And Sustainable Packaging Will Transform Global Healthcare
Key Takeaways Proprietary drug delivery innovations and sustainable packaging recognition are driving revenue growth, margin expansion, and strengthening competitive positioning. Strategic expansion in Asia-Pacific and operational efficiency improvements are diversifying revenues, optimizing costs, and supporting long-term market leadership.
View narrative
US$171.50
FV
19.1% undervalued
intrinsic discount
6.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
ATR
ATR
AptarGroup
Your Fair Value
US$
Current Price
US$138.72
1.8% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
5b
2015
2018
2021
2024
2025
2027
2030
Revenue US$4.9b
Earnings US$526.2m
Advanced
Set Fair Value